1 / 12

Global Vascular Closure Devices VCDs Market Forecast , Size and its Share

This presentation provides a clinical and commercial forecast of the global Vascular Closure Devices (VCDs) market, analyzing its size and regional share. The report evaluates how these devices improve procedural efficiency and patient outcomes by enabling rapid hemostasis after catheter-based interventions. It assesses market penetration by product type and access site, highlighting the pivotal shift to transradial access and ongoing technological innovations.

Omkar42
Download Presentation

Global Vascular Closure Devices VCDs Market Forecast , Size and its Share

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Vascular Closure Devices (VCDs) Market Welcome to the presentation on the Global Vascular Closure Devices Market. This report provides a comprehensive overview of the market landscape, including revenue growth from 2021 to 2033, future CAGR, regional and country-wise forecasts, key market drivers, restraints, and strategic insights. According to Cognitive Market Research, the VCDs market is experiencing strong momentum driven by innovation and increasing cardiovascular procedures globally.

  2. Global Market Size & Growth Forecast (2021–2033) $1,293.5M $1,710.4M 2021 Market Value 2025 Projection Global Vascular Closure Devices market valuation Expected market value by 2025 $2,990.6M 7.234% 2033 Forecast CAGR (2025-2033) Projected market value by 2033 Compound Annual Growth Rate The global Vascular Closure Devices market was valued at $1,293.5 million in 2021, is expected to reach $1,710.4 million in 2025, and will surge to $2,990.6 million by 2033. This reflects a robust CAGR of 7.234% from 2025 to 2033, underpinned by the increasing demand for faster hemostasis, reduced complication rates, and shorter hospital stays post-angiography or catheterization procedures.

  3. Key Market Drivers & Restraints Key Drivers: Key Restraints: • Growing Cardiovascular Interventions: Rising incidence of cardiovascular diseases is driving more catheterization procedures, fueling demand for effective closure solutions. • High Cost of Devices: Price sensitivity, especially in emerging economies, can limit adoption. • Risk of Complications: Improper use or placement may lead to vascular complications, hampering confidence in device efficacy. • Technological Advancements: Innovations such as bioabsorbable VCDs and next-gen suture-based systems enhance procedural outcomes.

  4. Emerging Market Trends 1 Shift Toward Minimally Invasive Procedures Physicians increasingly prefer VCDs over manual compression due to faster patient ambulation. 2 R&D Investments Companies are heavily investing in research for developing safer, faster, and more efficient closure technologies. 3 Adoption in Emerging Markets Growing awareness and rising healthcare infrastructure in Asia and Latin America are unlocking new opportunities.

  5. Top Companies in the Market Abbott Laboratories Cardinal Health Terumo Corporation Leading innovator in vascular closure technology with extensive global reach. Comprehensive portfolio of vascular closure solutions for various clinical needs. Japanese multinational with growing influence in the global VCDs market. Teleflex Incorporated Cardiva Medical Specialized in innovative medical technologies for vascular access and closure. Acquired by Haemonetics, known for novel vascular closure solutions. These companies are leading through robust product portfolios, geographical reach, and strategic collaborations.

  6. Top Countries Forecast – All Years Revenue & CAGR Country 2021 (M USD) 2025 (M USD) 2033 (M USD) CAGR (2025–2033) United States $405.1 $524.7 $880.0 6.68% China $93.8 $129.2 $246.1 8.39% India $48.8 $68.7 $136.7 8.97% Germany $58.4 $76.9 $136.6 7.45% Brazil $31.0 $41.4 $73.2 7.41% UAE $11.1 $15.2 $28.3 8.07% South Africa $15.6 $22.4 $39.1 7.23% 2021 (M USD) 2025 (M USD) 2033 (M USD)

  7. Regional Insights & Highlights North America Asia Pacific Remains the largest market, driven by high procedural volumes and early adoption of new technologies. Is the fastest-growing region with a CAGR of 8.18%, led by India and China. Middle East & Africa Europe Show rising adoption due to expanding cardiovascular care infrastructure. Continues to grow steadily, with Germany and the UK as key contributors.

  8. Future Opportunities in the Market Biodegradable VCDs Ambulatory Surgical Centers (ASCs) Strategic Partnerships The development of fully absorbable closure devices opens a new frontier. Rising number of outpatient cardiac interventions boosts device demand. Collaborations between med-tech companies and hospitals for training and access can expand adoption in Tier-2 and Tier-3 regions.

  9. Conclusion In conclusion, according to Cognitive Market Research, the Vascular Closure Devices market is poised for significant growth through 2033, driven by innovation, procedural volume growth, and evolving healthcare delivery models. For more information visit our report: Click here

  10. COGNITIVE MARKET RESEARCH TRUSTED BY GLOBAL INDUSTRY LEADERS Cognitive Market Research is a global market intelligence and consulting firm trusted by decision-makers in over 100 countries. Headquartered in the U.S., with offices in the U.K., India, and other strategic regions, we offer 24/7 support and seamless global coordination. Our expertise spans across 15+ industries, including healthcare, chemicals, energy, technology, consumer goods, manufacturing, automotive, and BFSI. We deliver scalable, client-centric solutions with quick turnaround times and a strong focus on quality. Supported by a skilled team of researchers, analysts, and data scientists, we use advanced analytics, proprietary tools, and deep domain knowledge to provide accurate, actionable insights. With a client-first approach, we’ve completed over 15,000 projects and 100,000+ interviews for startups, SMEs, Fortune 500s, and government agencies. Our tech-enabled, expert-driven methodologies make us a trusted partner for strategic decisions, innovation, and sustainable growth. WWW.COGNITIVEMARKETRESEARCH.COM

  11. RESEARCH METHODOLOGY CERTIFICATIONS & GLOBAL TRUST • 1. PRIMARY RESEARCH • Methods: Surveys, interviews, focus groups, consumer observation • Expert inputs: KOLs, C-level leaders, customers • 2. SECONDARY RESEARCH • Sources: Industry reports, databases (Statista, Factiva), • corporate filings • 3. DATA VALIDATION • Bottom-Up + Top-Down analysis • Triangulation with internal and external sources • 4. DELIVERABLES • REPorts in PPT, PDF, Word • SaaS platform and dashboard-based formats WWW.COGNITIVEMARKETRESEARCH.COM

  12. SPEAK TO ANALYST sales@cognitivemarketresearch.com USA: (+1) 312-376-8303 Europe and UK: (+44) 20-8144-9523 Asia Pacific: (+852) 81930785 India: (+91) 983-496-8611 WWW.COGNITIVEMARKETRESEARCH.COM

More Related